It's been quite the week for Blade Air Mobility Inc. NASDAQ: BLDE. On August 4, Blade and Joby Aviation Inc. NYSE: JOBY announced the sale of Blade's passenger mobility business to Joby for up to $125 million.
Blade Air Mobility sold its passenger/UAM division to Joby Aviation, shifting focus to medical organ transport and rebranding as Strata Critical Medical. The deal improves Blade's capital position but sacrifices the higher-growth air taxi opportunity, disappointing original investment expectations. Strata now controls 30% of the organ logistics market, with strong growth, solid profitability, and trades at an attractive valuation below 1x sales.
Blade Air Mobility, Inc. (NASDAQ:BLDE ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Mathew Schneider - Vice President of Investor Relations & Strategic Finance Melissa M. Tomkiel - President, General Counsel & Corporate Secretary Robert S.
| Passenger Airlines Industry | Industrials Sector | Robert S. Wiesenthal CEO | NASDAQ (CM) Exchange | 092667104 CUSIP |
| US Country | 310 Employees | - Last Dividend | - Last Split | - IPO Date |
Blade Air Mobility, Inc. is a pioneering company in the air mobility sector, offering innovative transportation solutions that aim to alleviate congestion on ground routes across the United States. Since its inception in 2014, the company has positioned itself as a key player in urban air mobility, providing efficient, time-saving travel options for both business and leisure purposes. Headquartered in New York, New York, Blade has expanded its services to include a variety of air travel options, appealing to a broad spectrum of customers seeking fast and convenient transportation alternatives.